Fructose: a key factor in the development of metabolic syndrome and hypertension.
Level 5 - mechanism / opinion, no new human data
Narrative review detailing biochemical mechanisms without original clinical or epidemiological trial data.
PubMed 23762544 · doi:10.1155/2013/682673
What was done
This paper reviews the biochemical pathways differentiating fructose metabolism from glucose metabolism in the liver, focusing on mechanisms linking fructose intake to uric acid production, insulin resistance, metabolic syndrome, and hypertension.
What was found
The abstract reports no empirical numbers or quantitative data. It describes the pathway whereby fructose bypasses glucokinase and phosphofructokinase, undergoing unregulated phosphorylation by fructokinase (KHK). This consumes ATP, depletes intracellular phosphate, activates AMP deaminase, and increases uric acid production, leading to endothelial dysfunction and insulin resistance.
Why it matters
It outlines specific enzymatic and metabolic mechanisms—specifically the unregulated action of fructokinase and subsequent uric acid accumulation—that explain how dietary fructose can contribute to metabolic syndrome and cardiovascular risk.
Limits
The abstract describes a narrative mechanistic review and provides no original experimental or clinical data, statistical comparisons, sample size, or measured effect sizes.
Cited by
- supports Hepatic fructose metabolism consumes ATP without a phosphate-scavenging pathway to return it, driving conversion of AMP into uric acid.